Adzymes and uses thereof
Details for Australian Patent Application No. 2003262937 (hide)
International Classifications
Event Publications
11 December 2003 Complete Application Filed
Priority application(s): 60/423,754 05.11.02 US; 60/406,517 27.08.02 US; 60/430,001 27.11.02 US
6 May 2004 Application Open to Public Inspection
Published as AU-B-2003262937
9 June 2005 Amendment Made
The nature of the amendment is: Delete the co-applicant Afeyan, Noubar B.
26 April 2007 Change of Name(s) of Applicant(s), Section 104
Compund Therapeutics, Inc. The name of the applicant has been changed to Adnexus Therapeutics, Inc.
8 January 2009 Assignment before Grant
Adnexus Therapeutics, Inc. The application has been assigned to Bristol-Myers Squibb Company
7 May 2009 Application Accepted
Published as AU-B-2003262937
3 September 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser